DEPT OF DEFENSE has floated a tender for 2024-25 Flu Vaccine. The project location is USA and the tender is closing on 16 May 2024. The tender notice number is HM047624P0009, while the TOT Ref Number is 100838504. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : 2024-25 Flu Vaccine

Deadline : 16 May 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 100838504

Document Ref. No. : HM047624P0009

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : DEPT OF DEFENSE
Contracting Office Address : SPRINGFIELD, VA 22150-7500
Primary Point of Contact : Mark Reynolds
Mark.A.Reynolds@nga.mil

Secondary Point of Contact : David Baer
david.s.baer@nga.mil
USA
Email :mark.a.reynolds@nga.mil

Tender Details

Description

The National Geospatial-Intelligence Agency (NGA) is issuing a combined synopsis/solicitation for a Request for Quote under Purchase Order number HM047624P0009. This requirement is for the Influenza Virus Vaccine for the 2024-2025 Influenza seasons. Please see the attached document for full details and requirements.
Active Contract Opportunity Notice ID HM047624P0009 Related Notice Department/Ind. Agency DEPT OF DEFENSE Sub-tier NATIONAL GEOSPATIAL-INTELLIGENCE AGENCY (NGA) Office ATTN: MS S84 - OCS
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: May 03, 2024 09:30 am EDT
Original Date Offers Due: May 16, 2024 05:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: May 31, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing

Place of Performance: Springfield, VA 22150 USA

Documents

 Tender Notice

Combined-Synopsis-Solicitation-2024-25-NGA-Flu-Vaccine.pdf

FY-25-SOW_NGA-Medical-Clinic-_Flu_Shot.pdf